-
Bio-Techne Announces Quarterly Cash Dividend: What Shareholders Need to Know
NASDAQ: $TECH A Commitment to Shareholder Value Bio-Techne Corporation (NASDAQ: TECH) has officially announced that its Board of Directors has declared a quarterly cash dividend. This move reflects the company’s ongoing dedication to delivering value to its investors while maintaining its position as a global leader in the life sciences sector. Dividend Details The company…
-
Azenta Prepares to Reveal Fiscal 2026 Financial Results
NASDAQ: $AZTA Mark Your Calendars for Azenta’s Fiscal Year-End Update Azenta, Inc. (Nasdaq: AZTA) has officially scheduled its conference call and webcast to discuss the company’s financial results for the fourth quarter and full fiscal year 2026. This event is a critical touchpoint for investors and stakeholders to gain insight into the company’s performance and…
-
Vanda Pharmaceuticals Sets Date for Q3 2026 Financial Results
NASDAQ: $VNDA Mark Your Calendars: Q3 2026 Financial Update Vanda Pharmaceuticals Inc. has officially announced that it will release its financial results for the third quarter of 2026 on Wednesday, October 28, 2026. This upcoming disclosure is a key event for investors and stakeholders looking to gauge the company’s performance throughout the quarter. How to…
-
Atrium Therapeutics Announces Q2 2026 Financial Performance
NASDAQ: $RNA Overview of Q2 2026 Results Atrium Therapeutics has officially released its financial results for the second quarter of 2026. As the company continues to navigate the complex biopharmaceutical landscape, these latest figures offer stakeholders a detailed look at the organization’s fiscal health and operational progress during the three-month period ending June 30, 2026.…
-
10x Genomics Scheduled to Present at 46th Annual TD Cowen Health Care Conference
NASDAQ: $TXG 10x Genomics, Inc., a prominent innovator in the fields of single cell and spatial biology, has confirmed its participation in a significant industry event next month. The company announced that key members of its management team are slated to present at the highly anticipated 46th Annual TD Cowen Health Care Conference. The scheduled…
-
Decoy Therapeutics Highlights Global Access Commitment Following Investor Presentation
NASDAQ: $DCOY Decoy Therapeutics Showcases Commitment to Global Accessibility During Recent Investor Event Decoy Therapeutics, Inc. recently participated in a dedicated segment during a virtual investor conference, focusing a significant portion of its presentation on the implications and execution strategy of its recently announced Global Access Commitment Agreement. The company utilized this platform to elaborate…